3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
43
Head and Neck Neoplasms
35
Nasopharyngeal Carcinoma
19
Oropharyngeal Neoplasms
17
Carcinoma, Squamous Cell
15
Rectal Neoplasms
13
Carcinoma, Non-Small-Cell Lung
13
Prostatic Neoplasms
11
Esophageal Squamous Cell Carcinoma
11
Mouth Neoplasms
8
Esophageal Neoplasms
8
Pancreatic Neoplasms
7
Laryngeal Neoplasms
7
Sarcoma
6
Tongue Neoplasms
5
Papillomavirus Infections
5
Lung Neoplasms
5
Hypopharyngeal Neoplasms
5
Glioblastoma
5
Brain Neoplasms
5
Stomatitis
4
Neoplasm Metastasis
4
Nasopharyngeal Neoplasms
4
Carcinoma
4
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Thyroid Carcinoma, Anaplastic
3
Lymphatic Metastasis
3
Gliosarcoma
3
Glioma
3
Interventions
Cisplatin
4
angiotensin I (1-7)
3
Radiotherapy
3
Radiation
3
Injections
3
Water
2
RRx-001
2
Interleukin 1 Receptor Antagonist Protein
2
Drug Therapy
2
Amifostine
2
tempol
1
peppermint oil
1
pegfilgrastim
1
kang-lai-te
1
hydrated silica gel-based toothpaste
1
golotimod
1
glucarpidase
1
fish oil triglycerides
1
calcium phosphate
1
brilacidin
1
anise oil
1
amlexanox
1
aluminum hydroxide, magnesium hydroxide, drug combination
1
Xylitol
1
Vaccinium myrtillus extract
1
Tramadol
1
Therapeutics
1
Surgical Procedures, Operative
1
Sorbic Acid
1
Sodium Bicarbonate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Mucositis
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT05966194
2024-11-15
KEVLARx
EpicentRx, Inc.
Phase 2
Recruiting
216 enrolled